Monoclonal antibodies (mAbs) play a pivotal role in biopharmaceutical research and production due to their precise targeting and therapeutic potential. The purification of mAbs is a critical step in ensuring the production of top-quality, safe, and efficient final products. Chromatographic methods such as affinity chromatography, ion exchange chromatography, and hydrophobic interaction chromatography (HIC) are commonly used to selectively capture and purify mAbs from complex mixtures. These methods exploit the unique properties of mAbs, such as antigen-binding specificity or surface charge and hydrophobicity, to achieve high purity levels. Recent advancements in mAb purification techniques include the use of multi-modal ligands, membrane adsorbers, and continuous processing, aiming to enhance efficiency, selectivity, and reliability while reducing processing time and costs. The selection of suitable purification methods based on the properties of the mAb and the desired quality attributes of the final product is crucial. This review delves into the current chromatographic techniques for mAb purification, highlighting the advancements and trends in the field.
In the realm of bio-pharmaceuticals, downstream processing holds equal importance to upstream processing in terms of economic value and sensitivity. Monoclonal antibodies, known for their impact on research, diagnosis, and clinical applications, have been extensively studied for purification methods. The CIPP strategy, consisting of capture, intermediate purification, and polishing steps, is often employed in mAb purification. Various chromatographic methods are utilized based on the physicochemical properties of the target mAb, accompanying impurities, and desired final purity levels. Affinity chromatography, a widely used method, offers high specificity in purifying mAbs by exploiting the affinity of proteins like protein A and protein G for the Fc-region. Ion exchange chromatography, developed to separate proteins based on charge, and HIC, which leverages hydrophobic interactions, are also essential in mAb purification. Selecting the appropriate purification strategies can streamline the process and improve overall efficiency in producing high-quality mAbs.
Affinity chromatography has been a cornerstone in mAb purification, with studies dating back to the early 1990s investigating factors such as sample application velocity and elution solvents’ impact on mAb structure and recovery. Recent research has focused on optimizing resins for mAb purification, exploring the dynamics of immunoglobulin separation, and developing new ligands to enhance purification efficiency. The integration of affinity chromatography with other techniques and the use of multimodal ligands have shown promise in improving mAb purification processes, leading to higher yields and purities. The successful purification of mAbs from various sources using affinity chromatography highlights its versatility and effectiveness in the biopharmaceutical industry.
Ion exchange chromatography, another key method in mAb purification, separates proteins based on their charge properties. Studies have investigated the optimization of resins, elution conditions, and gradient slopes to achieve high purity levels in mAbs. The development of weak partitioning chromatography modes and analytical techniques using ion exchange chromatography has further improved the separation and characterization of mAbs. The utilization of cross-interaction chromatography for antibody screening and charge variant purification has shown promising results in enhancing mAb quality and efficacy. The continuous advancements in ion exchange chromatography techniques contribute to the ongoing refinement of mAb purification processes, ensuring high-quality therapeutic proteins for various applications.
Hydrophobic interaction chromatography (HIC) serves as a valuable method for polishing mAbs by selectively capturing hydrophobic variants and removing impurities. While HIC offers non-denaturing conditions and orthogonal separation mechanisms, challenges such as high salt requirements and lower yields compared to other techniques exist. Recent studies have focused on optimizing HIC parameters, analyzing protein adsorption behaviors, and utilizing novel resins to enhance mAb purification efficiency. The application of HIC as a polishing step after affinity chromatography has proven beneficial in achieving ultra-pure mAbs for therapeutic use. Ongoing research aims to address the limitations of HIC, further improving its efficacy in mAb purification processes.
Hydrophilic interaction liquid chromatography (HILIC) has emerged as an alternative to traditional reversed-phase liquid chromatography for mAb purification, offering advantages such as increased sensitivity and orthogonal selectivity. Despite challenges in retention behavior and retention mechanism descriptions, HILIC plays a crucial role in isolating polar compounds and analyzing glycosylation patterns in mAbs. Recent studies have optimized HILIC parameters for different mAb types, enabling efficient identification of hydrophilic variants and characterization of protein glycosylation patterns. The continuous development of HILIC techniques contributes to enhancing the purification and analysis of mAbs, ensuring their quality and efficacy in therapeutic applications.
Size exclusion chromatography (SEC) is a versatile method used for purifying mAbs after other chromatographic steps, effectively removing aggregates and impurities. SEC operates under gentle conditions, separating proteins based on size relative to molecular weight using porous resins. While SEC offers non-destructive purification and efficient removal of impurities, challenges such as protein size limitations and costly gel filtration matrices exist. Recent research has focused on optimizing SEC parameters, enhancing column efficiency, and characterizing intact monoclonal antibody oligomers using mass spectrometry. The utilization of SEC as a polishing step alongside other chromatographic techniques has proven beneficial in achieving high-purity mAbs for various biopharmaceutical applications. The continuous improvements in SEC methodologies contribute to advancing mAb purification processes and ensuring the production of high-quality therapeutic proteins.
Mixed-mode chromatography (MMC) and multi-column chromatography (MCC) techniques have revolutionized mAb purification by integrating various interactions into a single resin or utilizing multiple columns with different stationary phases. MMC and MCC offer high selectivity and capacity, effectively removing aggregates and impurities in mAbs. MMC combines weak anion exchange/hydrophobic interaction for efficient protein purification, while MCC employs multiple columns in parallel to enhance throughput and purity. Recent studies have focused on optimizing MMC resins, studying protein-ligand interactions, and exploring novel membrane systems for mAb purification. The continuous advancements in MMC and MCC techniques contribute to improving the efficiency and productivity of mAb purification processes, ensuring the production of high-quality therapeutic proteins for diverse applications.
Simulated moving bed chromatography (SMB) stands out as a continuous purification method for mAbs, offering higher productivity, purity, and lower solvent consumption compared to traditional batch methods. SMB utilizes multiple resin beds that shift positions to mimic resin movement, achieving continuous operation and maximizing adsorption efficiency. Recent research has highlighted the benefits of SMB over conventional methods, emphasizing its efficiency in resin utilization and labor costs reduction. The integration of SMB with other chromatographic techniques further enhances mAb purification processes, ensuring the production of high-purity therapeutic proteins for various biopharmaceutical applications. The continuous advancements in SMB technology contribute to streamlining mAb purification processes and improving overall production efficiency.
In conclusion, the purification of monoclonal antibodies using chromatographic methods plays a crucial role in ensuring the production of high-quality, safe, and efficient therapeutic proteins. Advancements in affinity chromatography, ion exchange chromatography, hydrophobic interaction chromatography, hydrophilic interaction liquid chromatography, size exclusion chromatography, mixed-mode chromatography, multi-column chromatography, and simulated moving bed chromatography have significantly enhanced the purification efficiency and yield of mAbs. By optimizing purification parameters, exploring novel resins and ligands, and integrating advanced techniques, researchers continue to improve mAb purification processes, paving the way for the development of innovative biopharmaceutical products with enhanced therapeutic efficacy.
Takeaways:
1. Chromatographic methods are essential for purifying monoclonal antibodies, ensuring high-quality therapeutic proteins.
2. Recent advancements in chromatographic techniques have improved mAb purification efficiency, selectivity, and yield.
3. Integration of advanced methods such as mixed-mode chromatography and simulated moving bed chromatography enhances mAb purification processes.
4. Ongoing research focuses on optimizing purification parameters, exploring novel resins, and improving overall production efficiency in mAb purification.
Tags: mass spectrometry, process development, monoclonal antibodies, upstream, formulation, downstream, inclusion bodies, bioreactor, automation, cell culture
Read more on pmc.ncbi.nlm.nih.gov